Hepatology
Spontaneous Bacterial Peritonitis
Diagnose SBP with prompt diagnostic paracentesis and ascitic neutrophil count, begin empiric therapy when PMNs reach 250/mm3, prevent renal deterioration with albumin when indicated, and actively exclude secondary peritonitis when the clinical or fluid profile is atypical.
Initial decision
Who needs immediate diagnostic paracentesis?
Use paracentesis to establish infection rather than relying on symptoms or Gram stain.
Perform diagnostic paracentesis in a patient with cirrhosis and ascites when SBP is clinically suspected, including fever, abdominal pain or tenderness, or other evidence of infection. Diagnostic paracentesis is the basis of diagnosis, and ascites is associated with substantial SBP risk: prevalence is approximately 1.5% to 3.5% among outpatients and about 10% among hospitalized patients with cirrhosis. easl eu+1easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
Send ascitic fluid for cell count with differential and culture. Culture-negative neutrocytic ascites is managed as SBP when the PMN count is greater than 250/mm3. Gram stain is frequently negative and should not delay empiric treatment. ScienceDirect+1ScienceDirectPeritoneum Exudate - an overview | ScienceDirect TopicsPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
Obtain targeted ascitic studies when the presentation points away from uncomplicated SBP: add ascitic amylase for suspected pancreatic ascites, mycobacterial culture or PCR when tuberculosis is suspected, and cytology when malignancy is suspected. Ascitic glucose and lactate dehydrogenase help assess for secondary peritonitis. PubMed+1PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI Bookshelf
PMN count greater than 250/mm3: diagnose SBP and start empiric antibiotics, irrespective of ascitic culture result. PubMedPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
PMN count less than 250/mm3 with fever above 37.8 degrees C, abdominal pain, or tenderness: give empiric antibiotics while cultures are pending. PubMedPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
Do not use a negative Gram stain to exclude SBP. ScienceDirectScienceDirectPeritoneum Exudate - an overview | ScienceDirect Topics
Acute treatment
Start empiric antibiotics once the PMN threshold is met
Select initial therapy by acquisition setting, local resistance patterns, and renal toxicity risk.
For presumed community-acquired SBP, a third-generation cephalosporin is a standard empiric option. Cefotaxime has guideline support and effective regimens include 2 g intravenously every 6 hours or every 12 hours; ceftriaxone 2 g intravenously every 24 hours is another reported regimen. Third-generation cephalosporins avoid the nephrotoxicity associated with aminoglycoside-containing empiric regimens. ScienceDirect+2ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsScienceDirectPeritoneum Exudate - an overview | ScienceDirect TopicsPubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract
Obtain ascitic fluid culture before antibiotics when this does not delay treatment, then narrow or modify therapy according to organism identification and susceptibility testing. Common implicated organisms include Escherichia coli, Klebsiella species, enterococci, and other gram-negative enteric flora; healthcare-associated and nosocomial SBP have greater multidrug-resistant and gram-positive pathogen concerns. ScienceDirect+2ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsWileyAntibiotic resistance in healthcare‐related and nosocomial ...PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
For healthcare-associated or nosocomial SBP, do not assume a community-acquired cephalosporin regimen will be adequate. EASL 2018 guidance emphasized adding gram-positive-active agents such as a glycopeptide, daptomycin, or linezolid in settings with high gram-positive infection prevalence; choose the regimen in conjunction with local antibiograms and the patient's prior antimicrobial exposure. PubMedPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Cefotaxime: 2 g IV every 6 hours or every 12 hours; reported total daily doses range from 4 to 12 g/day. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Ceftriaxone: 2 g IV every 24 hours. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Ceftazidime: 2 g IV every 8 to 12 hours. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Amoxicillin-clavulanate: 1 g/0.2 g IV every 8 hours is a reported alternative regimen. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Modify empiric therapy when culture and susceptibility results are available. ScienceDirect+1ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsScienceDirectPeritoneum Exudate - an overview | ScienceDirect Topics
When to broaden beyond a standard cephalosporin regimen
Treat healthcare-associated and nosocomial SBP as a resistance-risk phenotype. Prior healthcare exposure, recent antimicrobials, or local high prevalence of multidrug-resistant organisms should trigger empiric regimen selection based on local microbiology rather than routine community-acquired coverage. Wiley+1WileyAntibiotic resistance in healthcare‐related and nosocomial ...PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
In high-prevalence gram-positive settings, guidance discusses glycopeptides, daptomycin, or linezolid as gram-positive-active components for healthcare-associated or nosocomial SBP. PubMedPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Avoid aminoglycoside-based empiric regimens when an effective third-generation cephalosporin option is available because of nephrotoxicity risk. ScienceDirectScienceDirectPeritoneum Exudate - an overview | ScienceDirect Topics
Renal protection
Use albumin to reduce hepatorenal complications
Treat SBP as a renal-risk event, not only an intra-abdominal infection.
Co-administer intravenous albumin with antibacterial therapy in SBP using 1.5 g/kg at diagnosis and 1 g/kg on day 3. In patients treated with cefotaxime, this strategy reduced the incidence of type 1 hepatorenal syndrome and mortality. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Follow renal function during acute infection because renal impairment after SBP has major prognostic implications and SBP is linked to hepatorenal syndrome. Worsening kidney function should prompt reassessment of infection control, circulatory status, and competing renal injury mechanisms rather than assuming uncomplicated SBP is resolving. ScienceDirect+2ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCPubMedDiagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. - Abstract
Day 1: albumin 1.5 g/kg IV at SBP diagnosis. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Day 3: albumin 1 g/kg IV. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Monitor kidney function closely during treatment because SBP can precipitate hepatorenal syndrome. ScienceDirect+1ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsPubMedDiagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. - Abstract
| Timing | Albumin dose | Purpose |
|---|---|---|
| At SBP diagnosis | 1.5 g/kg IV. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics | Reduces type 1 hepatorenal syndrome and mortality when used with cefotaxime. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics |
| Day 3 | 1 g/kg IV. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics | Completes the studied two-dose regimen. ScienceDirectScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics |
Diagnostic escalation
When should SBP be reconsidered as secondary peritonitis?
Failure of expected clinical improvement requires a search for a surgically or procedurally correctable source.
SBP requires infection of ascites without a contiguous intra-abdominal source such as bowel perforation or intra-abdominal abscess. If abdominal findings are disproportionate, the ascitic fluid profile is atypical, or the patient fails to improve on appropriate empiric therapy, evaluate for secondary bacterial peritonitis rather than simply extending the original regimen. ScienceDirect+2ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topicseasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedAscites - StatPearls - NCBI Bookshelf
Use ascitic glucose and lactate dehydrogenase as part of the secondary-peritonitis assessment, then direct imaging and source-control evaluation to the suspected pathology. Pancreatitis and tuberculosis should be pursued selectively with ascitic amylase and mycobacterial culture or PCR, respectively, rather than applying those tests routinely. PubMed+1PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI Bookshelf
Do not equate ascitic culture negativity with treatment failure or diagnostic exclusion. A PMN count greater than 250/mm3 establishes SBP even if cultures are negative; the key reassessment question is whether the clinical course and fluid findings remain consistent with a spontaneous rather than secondary source. PubMed+1PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCGastroenterologyUtility of an Algorithm in Differentiating Spontaneous From ...
Possible perforation or abscess: investigate for secondary peritonitis and source control. ScienceDirect+1ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topicseasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Suspected peritoneal tuberculosis: obtain mycobacterial culture or PCR. PubMedPubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract
Suspected malignancy: send ascitic cytology. PubMedPubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract
Recurrence prevention
Who needs antibiotic prophylaxis after SBP or gastrointestinal bleeding?
Use prophylaxis in the highest-risk settings while accounting for resistance selection.
After recovery from SBP, prescribe long-term secondary prophylaxis with daily norfloxacin or trimethoprim-sulfamethoxazole. Norfloxacin and trimethoprim-sulfamethoxazole have similar efficacy for SBP prevention. Wiley+1WileyReview article: spontaneous bacterial peritonitis - Wiley Online LibraryPubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
During gastrointestinal hemorrhage in a patient with cirrhosis, give antibacterial prophylaxis for 7 days. AASLD guidance cited intravenous ceftriaxone or oral norfloxacin; start with a parenteral antibiotic during active bleeding and transition to an oral agent when oral intake resumes, completing 7 days total. PubMedPubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
For primary prophylaxis in selected patients with cirrhosis and ascites, guideline appraisals describe long-term norfloxacin 400 mg daily in those with low ascitic fluid protein. Ciprofloxacin is an alternative to norfloxacin, but AASLD preference for daily rather than weekly ciprofloxacin reflects concern that weekly dosing may increase quinolone resistance. PubMed+1PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Secondary prophylaxis after prior SBP: daily norfloxacin or daily trimethoprim-sulfamethoxazole. PubMedPubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
Gastrointestinal hemorrhage: ceftriaxone IV or norfloxacin orally for a total of 7 days; begin parenterally during active bleeding if needed. PubMedPubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
Primary prophylaxis described in guideline appraisals: norfloxacin 400 mg orally daily in patients with low ascitic fluid protein. PubMedPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Ciprofloxacin is an alternative, but daily dosing is preferred over weekly dosing in AASLD-cited guidance because of quinolone-resistance concerns. PubMedPubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
References
- Spontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- Peritoneum Exudate - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- Review article: spontaneous bacterial peritonitis - Wiley Online Library — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Management of bacterial infections in cirrhosis - ScienceDirect.com — www.sciencedirect.com · www.sciencedirect.com
- Antibiotic resistance in healthcare‐related and nosocomial ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Hepatorenal syndrome type 1 and bacterial infection: A catastrophic ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Prevention and Management of Bacterial Infections in Cirrhosis — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- The impact of infection by multidrug- resistant agents in ... - Wiley — aasldpubs.onlinelibrary.wiley.com · aasldpubs.onlinelibrary.wiley.com
- The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- [PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL — easl.eu · easl.eu
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. - Abstract — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- Ciprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- [PDF] EASL Clinical Practice Guidelines for the management of patients ... — easl.eu · easl.eu
- Management of Ascites, Spontaneous Bacterial Peritonitis ... - EASL — easl.eu · easl.eu
- Spontaneous Bacterial Peritonitis: We Are Still Behind - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- KASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome | Cleveland Clinic Journal of medicine — www.ccjm.org · www.ccjm.org
- Cirrhosis & Complications Archives - EASL-The Home of Hepatology. — easl.eu · easl.eu
- Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. - Abstract — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- Chronic Liver Disease - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Ascites - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Editorials - Gastroenterology — www.gastrojournal.org · www.gastrojournal.org
- Utility of an Algorithm in Differentiating Spontaneous From ... — www.gastrojournal.org · www.gastrojournal.org